Computer-assisted drug repurposing for thymidylate kinase drug target in monkeypox virus
Frontiers in Cellular and Infection Microbiology · 2023
DOI: 10.3389/fcimb.2023.1159389 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2023. Verfasst von Amar Ajmal und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Computational Medicinal Chemistry Laboratory, Abdul Wali Khan University, Mardan, Pakistan. Hauptthemen laut MEDLINE: Monkeypox virus, Mpox, Monkeypox. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Monkeypox is a zoonotic disease caused by brick-shaped enveloped monkeypox (Mpox) virus that belongs to the family of ancient viruses known as Poxviridae. Subsequently, the viruses have been reported in various countries. The virus is transmitted by respiratory droplets, skin lesions, and infected body fluids. The infected patients experience fluid-filled blisters, maculopapular rash, myalgia, and fever. Due to the lack of effective drugs or vaccines, there is a need to identify the most potent and effective drugs to reduce the spread of monkeypox. The current study aimed to use computational methods to quickly identify potentially effective drugs against the Mpox virus.
Methods
In our study, the Mpox protein thymidylate kinase (A48R) was targeted because it is a unique drug target. We screened a library of 9000 FDA-approved compounds of the DrugBank database by using various in silico approaches, such as molecular docking and molecular dynamic (MD) simulation.
Results
Based on docking score and interaction analysis, compounds DB12380, DB13276, DB13276, DB11740, DB14675, DB11978, DB08526, DB06573, DB15796, DB08223, DB11736, DB16250, and DB16335 were predicted as the most potent. To examine the dynamic behavior and stability of the docked complexes, three compounds—DB16335, DB15796, and DB16250 —along with the Apo state were simulated for 300ns. The results revealed that compound DB16335 revealed the best docking score (-9.57 kcal/mol) against the Mpox protein thymidylate kinase.
Discussion
Additionally, during the 300 ns MD simulation period, thymidylate kinase DB16335 showed great stability. Further, in vitro and in vivo study is recommended for the final predicted compounds.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, Computational Medicinal Chemistry Laboratory, Abdul Wali Khan University, Mardan, Pakistan.
- Center for Medical Genetics and Hunan Key Laboratory of Medical Genetics, School of Life Sciences, Central South University, Changsha, Hunan, China.
- Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Al-Quwayiyah, Shaqra University, Riyadh, Saudi Arabia.
- Department of Life Sciences, School of Science, University of Management and Technology (UMT), Lahore, Pakistan.
- Department of Pharmacology and Toxicology, College of Pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia.
- Institute of Biomedical Sciences, Shanxi University, Taiyuan, China.
Zitieren
APA
Ajmal, A., Mahmood, A., Hayat, C., Hakami, M. A., Alotaibi, B. S., Umair, M., Abdalla, A. N., Li, P., He, P., Wadood, A., & Hu, J. (2023). Computer-assisted drug repurposing for thymidylate kinase drug target in monkeypox virus. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2023.1159389
Vancouver
Ajmal A, Mahmood A, Hayat C, Hakami MA, Alotaibi BS, Umair M, et al. Computer-assisted drug repurposing for thymidylate kinase drug target in monkeypox virus. Frontiers in Cellular and Infection Microbiology. 2023. doi:10.3389/fcimb.2023.1159389
BibTeX
@article{Ajmal2023,
author = {Ajmal, Amar and Mahmood, Arif and Hayat, Chandni and Hakami, Mohammed Ageeli and Alotaibi, Bader S and Umair, Muhammad and Abdalla, Ashraf N and Li, Ping and He, Pei and Wadood, Abdul and Hu, Junjian},
title = {Computer-assisted drug repurposing for thymidylate kinase drug target in monkeypox virus},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2023},
doi = {10.3389/fcimb.2023.1159389}
}
EUVIMED